Organic Holds at 5% and Thrive Grows to $600M, but the Margin Stays Flat: The 19th Year Now Rides on Q4 Alone

Results vs. Consensus

Q3 2026 Scorecard

Year-over-Year Comparisons

Quarter-over-Quarter Comparisons

The third quarter is Marsh's seasonal low for revenue and margin: reinsurance renewals cluster at January 1, April 1 and June 1, and much of the property book renews in the first half. The sequential drops in revenue, margin and EPS are calendar effects. The sequential signals that matter are the one-point acceleration in Risk to 5%, the recovery in Health and Benefits from 3% to 5%, and the deeper decline in Reinsurance against a demanding prior-year quarter.

Revenue

Consolidated revenue grew 8% reported and 5% underlying, the same underlying rate as Q2, leaving the nine-month underlying rate at 5%, a point above the 4% Marsh delivered for 2025. That matters because the full-year guide is still "similar to last year," so the company is running ahead of its own framework three quarters in. The composition improved where it counts most: Risk, the largest and highest-quality revenue stream, accelerated to 5% with U.S./Canada at 4% and International at 6%. Consulting grew 8%, led by a 14% Management Consulting quarter. Reinsurance was the one decline at 6%, in what management called a small quarter against a prior-year period that benefited from non-recurring items. The reported 8% growth carries roughly three points from acquisitions and the Deasterra gain, so the underlying figure is the right read.

Margins

This is where the quarter fell short of our test. The adjusted operating margin was 22.7%, the same as a year ago to the decimal: Risk and Insurance Services slipped 10 basis points to 24.6% and Consulting held at 22.1%. Adjusted operating income grew 6%, in line with adjusted revenue, which is why the margin held flat. Through nine months the adjusted margin is 28.1% against 28.2% a year ago. Management did not hide it; the CEO said plainly on the call that "margins were flat." The explanations are the same ones offered in July: deliberate investment in sales capacity, which Thrive savings are funding "at a higher rate this quarter," and a shrinking, high-margin Reinsurance book. Both are credible. Neither changes the arithmetic that every basis point of the promised full-year expansion now has to come from the fourth quarter.

EPS, Cash Flow & Capital Return

Adjusted EPS of $2.03 grew 10%: adjusted net income rose 6.7% to $972M and the diluted share count fell 3.0% to 479M. GAAP EPS of $1.69 grew 12%, with the Deasterra gain's tax treatment pulling the GAAP effective tax rate down to 21.4%. The firm repurchased $500M of stock (2.7M shares) in Q3, taking the year to $2.0B (11.4M shares), and paid $476M in dividends. The weaker spot is cash. Nine-month operating cash flow was $2.3B against $3.1B a year ago (down 26%), as receivables absorbed $872M (vs. $388M), restructuring cash rose to $222M, and Greensill settlement payments ran through the statement. Commercial paper of $1.6B funded part of the gap, and total debt ended the quarter at $20.5B. We read most of the cash shortfall as timing plus one-off legal payments rather than a change in conversion, but it is worth tracking into year-end: the fourth quarter delivered about 41% of 2025's $5.3B of operating cash flow.

Segment Performance

Segment Revenue Mix: Q3 2026

Risk by Geography: Q3 2026

EMEA's 22% reported growth is inflated by acquisition effects, including the Deasterra remeasurement gain (Deasterra is a Spanish broker), which account for 16 of the 22 points. Its 7% underlying growth is the comparable figure.

People and Investments by Practice: Q3 2026

Risk: Accelerating Through a Falling Rate Index

Risk grew 10% reported and 5% underlying, up from 4% in Q2 and matching the best pace in our coverage window (5% in Q2 2025). U.S./Canada held at 4% and International stepped up to 6%, led by EMEA at 7% and Asia Pacific at 4%, with Latin America flat. The 10-Q attributes the growth to "higher new business and renewal revenue, partially offset by declining insurance premium rates." Management named digital infrastructure and transactional risk as the standout demand pockets, and pointed to London wholesale, specialty and facultative reinsurance as the EMEA drivers. The rate backdrop was mildly less hostile: the firm's global index fell 5% after a 6% decline in Q2, and the U.S. was down only 1%.

"We had really strong growth, very high single digit growth in new business, strong growth in specialties, And actually, so specialty wise growth in cyber, credit, marine,"
— Nick Studer, CEO, Risk

Assessment: The most important line in the release. A 5% organic print from the flagship broker, against a 5% decline in its own pricing index, is direct evidence that new business and specialty mix can carry growth through a soft market. It answers the deceleration worry that defined 2025 for the second quarter running, and it is the main reason we stay constructive despite the margin.

Reinsurance: A Small Quarter in a Soft Market

Reinsurance revenue fell 6% to $374M on both a reported and underlying basis, after a 2% decline in Q2. The third quarter is the segment's smallest, so a few non-recurring items in the prior-year period distort the comparison; through nine months the business is down 1% underlying, which management says "better reflects" the year. The underlying problem is price: property-cat reinsurance capacity is abundant from both traditional reinsurers and alternative capital, catastrophe losses have been benign, and management expects soft conditions to persist through the January 1 renewals. Client retention remains in the high 90s and new business is strong, but neither offsets the rate decline.

"Q3 is a small quarter for reinsurance. And revenue was impacted by continued softness in property reinsurance rates as well as a tough comparison to a strong third quarter last year that benefited from non recurring items."
— Mark McGivney, COO & CFO

Assessment: The cyclical trough is lasting longer than we assumed at the start of the year, and the January 1 outlook offers no relief. The minus-1% nine-month figure is a fairer read than the minus-6% quarter, but Reinsurance is now the one business where we expect negative organic growth into early 2027. It is also a high-margin book, which is part of why the consolidated margin is stuck.

People and Investments: Health Recovers, Workforce Slips

People and Investments grew 6% reported and 5% underlying. Investments and Retirement grew 8%, led by investment management, and assets under management of $843B were flat sequentially and up 23% year over year. Health and Benefits recovered to 5% from Q2's 3%, with growth in every region and particularly International, which supports management's July argument that the dip was noise. Workforce and Rewards fell 1%, as growth in the U.S. and most of International was offset by a difficult Middle East environment.

"Workforce and Reward was down 1%. With growth in the U.S. and most of International offset by the impact of a challenging environment in the Middle East."
— Mark McGivney, COO & CFO

Assessment: A clean quarter for the most recurring business in the group. Health's return to 5% closes a commitment we were watching, and the investments franchise keeps compounding on new business and markets. Workforce and Rewards is small (about a fifth of the segment) and its decline is geographic, so we treat it as a watch item rather than a trend.

Management Consulting: 14%, With a Quarter Borrowed From Q4

Management Consulting grew 14% on both a reported and underlying basis, well above the "mid-to-high single digits" management guided in July. Demand was broad across industries and regions, and the Quotient AI-transformation practice was again the fastest-growing part of the portfolio. The quarter also benefited from success fees management had expected in Q4, a growing feature of a fee model that increasingly links pay to client outcomes. Management now expects high-single-digit growth for the full year, which it says implies a roughly flat Q4.

"The quarter also benefited from favorable timing on success fees that we had expected in the fourth quarter. For the full year, management consulting is on pace for high single digit growth. Which would imply a roughly flat top line in Q4 due in part to the timing I mentioned."
— Mark McGivney, COO & CFO

Assessment: An excellent nine months (11% underlying) for the most AI-levered business in the group, but the Q3 figure overstates the run rate. The same pattern appeared a year ago, when success fees flattered Oliver Wyman's Q3 and management warned that Q4 would moderate. A flat Q4 in a high-margin unit is one more headwind for the fourth-quarter margin bridge.

Key KPIs

Key Topics & Management Commentary

Overall Management Tone: Confident, consistent with the prior two calls, and more expansive on strategy than on numbers. Management led with growth, the Thrive upsizing and AI, conceded the flat margin without elaboration, and recast margin expansion as an outcome of running the business well rather than a target, a subtle but real shift from July's guide of "more margin expansion in the fourth quarter than in the third quarter." Questions on 2027, on the size of the consulting pull-forward and on digital-infrastructure revenue were all deferred or declined, which kept the call on message but left the quantitative gaps intact.

1. Underlying Growth Held at 5%, and Risk Accelerated

Consolidated underlying growth was 5% for the second straight quarter, with Risk at 5%, People and Investments at 5% and Management Consulting at 14%, against a minus-6% Reinsurance print. Nine-month underlying growth is also 5%, a point ahead of 2025's full-year rate and ahead of the "similar to last year" guide management again reaffirmed.

"Overall, revenue grew 8% in the quarter. Underlying revenue growth was 5%, adjusted operating income grew 6%, and adjusted EPS grew 10%."
— John Doyle, President & CEO

The acceleration in Risk is the most durable component. Management tied it to new-business strength, specialty lines, digital infrastructure and transactional risk, and to continued producer hiring. The guide was not raised despite the 5% run rate, which we read as deliberate conservatism given the soft reinsurance setup for January 1 and a flat Q4 in Management Consulting.

Assessment: Growth is no longer the debate. Three quarters at 4-5% with the flagship broker accelerating means the 2025 deceleration bear case has lost its evidence. The unraised guide is a cushion, not a warning.

2. The Margin Did Not Turn in Q3

The adjusted operating margin was flat at 22.7%, the nine-month margin is 10 basis points below last year, and management reiterated a full-year expansion that now rests entirely on Q4. Risk and Insurance Services lost 10 basis points; Consulting held flat; corporate expense was a little lower.

"Looking ahead, we continue to expect underlying revenue growth in 2026 similar to last year. We also anticipate another year of margin expansion and solid adjusted EPS growth."
— John Doyle, President & CEO

Unlike July, management offered no phasing language for Q4. The fourth-quarter guide items point the wrong way on the margin: adjusted corporate expense rises to about $80M (from $68M in Q3), fiduciary income dips to about $94M, and Management Consulting is expected to be roughly flat after borrowing success fees in Q3. The offsets are Thrive savings, the producer hires maturing, and Q4's seasonally favorable mix.

Assessment: The commitment we flagged as the primary 2026 risk was not met in Q3. We still lean toward delivery in Q4 given the firm's record and the Thrive ramp, but the probability has fallen, and a miss would end an 18-year streak that investors treat as part of the franchise. This is now the single variable that matters most for the stock into January.

3. Thrive Upsized: $600M of Savings, $750M of Costs

Management raised the Thrive savings target to $600M from $400M, citing greater opportunity in Business and Client Services and in technology, and raised expected program costs to about $750M from $500M. Most actions are to be taken by the end of 2028, with savings realized fairly evenly across the program's three years. Savings to date have come from simplifying the organization, right-shoring and BCS efficiencies. The 10-Q shows $310M of program costs incurred through September, $71M of it in Q3.

"When we launched Thrive a year ago, we targeted $400 million in savings. We are now seeing greater opportunities coming from our Business and Client Services or BCS and advances in technology. As a result, we are increasing our Thrive savings target to $600 million. The expanded savings will create additional capacity to invest in sales, new capabilities, our brand, and technology."
— John Doyle, President & CEO

The program also absorbed the brand transition, which management completed several months early: Guy Carpenter now reports as Reinsurance and Mercer as People and Investments, with every business under the single Marsh name. The release described the quarter as one in which the firm "successfully completed our brand transition."

Assessment: The most valuable disclosure of the quarter for 2027. An extra $200M of gross savings is worth roughly 70 basis points of margin on a ~$28B revenue base if it all fell through, but management was explicit that it creates "additional capacity to invest," so the net margin benefit will be smaller. The cost-to-savings ratio stayed reasonable at about 1.25x. Thrive is the lever that makes a 2027 margin expansion plausible even with Reinsurance soft.

4. Greensill Is Settled

The Q3 noteworthy items included a $144M charge, net of insurance recoveries, for the Greensill litigation in Australia, bringing the 2026 total to $569M after Q1's $425M. The 10-Q says the settlements with White Oak, Greensill Bank and Credit Suisse "conclude Marsh's involvement in the Australian proceedings," and management expects no further charges. The applicants in those proceedings had claimed about $5B of losses.

"As disclosed in our 10 Q this morning, we have settled our involvement in this litigation. And do not expect any additional charges relating to the case. Note that total settlement payments and costs are reflected in our statement of cash flow."
— Mark McGivney, COO & CFO

Assessment: A tail risk retired. The total cost, about $569M net of insurance, equals roughly 11% of 2025's $5.0B of free cash flow, and resolving a $5B claim at that price is a reasonable outcome. The cost did not disappear, however: the settlement cash is part of why nine-month operating cash flow fell 26%. We remove Greensill from the watch list.

5. Management Consulting's Strength, and Its Timing

Management Consulting's 14% growth was the quarter's biggest positive surprise against guidance. Management credited broad demand, AI-related work, and a shift toward outcome-based fees, which brought some success fees into Q3 from Q4. It declined to size the pull-forward but said it did not explain most of the growth.

"This great result reflected strong demand and delivery across the business especially in AI related work."
— Mark McGivney, COO & CFO

Through nine months the unit is up 11% underlying. Guidance for high-single-digit full-year growth implies Q4 near flat, so the full-year number is roughly what management expected in July, with the timing shifted.

Assessment: The demand signal is real, and the move to success pricing ties the business's revenue more directly to the value it creates, which should support pricing power over time. The cost is lumpier quarters. For modeling, we treat Q3 and Q4 as one half and keep the full-year view at high single digits.

6. Reinsurance: Soft Through January 1

Management's market commentary on reinsurance was unambiguous: short-tail capacity is abundant, catastrophe losses have been light, capital is growing, and the soft market should persist through the January 1 renewal cycle. In casualty reinsurance, capacity is adequate and reinsurers are pricing on claims experience and data quality, with clients exploring sidecars for liability books.

"Property cat reinsurance losses have been relatively benign this year. And capital is increasing. Adding to competitive market environment. We expect these conditions to persist through the January 1 renewal cycle."
— John Doyle, President & CEO

In Q&A, management added that Marsh's reinsurance book is overweight property-cat and the U.S. relative to peers, and that industry consolidation among clients has been a further drag this year.

Assessment: No relief before 2027. January 1 is the largest renewal date for the business, so we model Reinsurance at slightly negative organic growth through the first quarter of 2027. The growth offsets (casualty, M&A advisory, alternative capital) are real, but they are not large enough yet to overcome property-cat pricing.

7. Pricing: The Index Fell 5%, Property Less Steeply

The Marsh Global Insurance Market Index fell 5% in Q3 after a 6% decline in Q2. Property fell 10% (12% in Q2), casualty rose 1% with U.S. excess casualty up 13%, cyber fell 4%, financial and professional liability fell 3% and workers' compensation 5%. By region, the U.S. was down 1%, Canada, Europe and Asia mid-single digits, the U.K. and Latin America high-single digits, and the Pacific double digits.

"Global property rates decreased 10%. Global financial and professional liability rates were down 3%, while cyber decreased 4%. Global casualty rates increased 1%, with US excess casualty up 13% reflecting inflationary pressure and loss costs."
— John Doyle, President & CEO

Management again stressed that the index skews to large accounts and that more of the firm's own property-cat renewals fall in the first half, so the Q3 mix is not directly comparable with Q2.

Assessment: The pricing drag is easing at the margin, with property less negative and the U.S. nearly flat. Casualty's cooling from +15% to +13% in U.S. excess is worth watching, since it has been the main offset. On balance, a market that falls 5% while Risk grows 5% is the thesis working as designed.

8. M&A: A String of Pearls, Not an Answer to Aon

With Aon's roughly $17B agreement to buy USI pending, one line of questioning asked whether Marsh feels pressure to match it. Management rejected the premise, citing more than 130 middle-market agency deals over 15 years and a preference for many small acquisitions. Activity continues: Marsh closed the purchase of the remaining 60% of Deasterra in July and a Japanese broker in September, and announced a top-100 Midwest agency on October 1. Nine-month acquisition spending was $607M.

"We have done over 130 deals since we began that strategy about 15 years ago. It cannot be replicated, and I would not change our business for any business in the market."
— John Doyle, President & CEO

Management also argued that scale will matter more in an AI-driven transition, and that others will find it difficult to invest at the same rate, which could improve the M&A pipeline over time, while noting that some gap between bid and ask remains for strategic buyers.

Assessment: The right answer for shareholders. Aon's stock fell sharply on its debt-funded deal, which paused its buybacks and dilutes 2027 earnings; Marsh avoiding a reactive large acquisition keeps buyback capacity intact at a reasonable multiple. If USI's integration disrupts the middle market, the established Marsh platform is positioned to recruit talent and clients from it.

9. AI in the Workflow: Workbench, Companion and the In-House Model

Management framed AI as a present factor rather than a future one. Examples included Marsh Risk Companion (an analytics suite for client risk programs), Broker Workbench (launched in Q3 for U.K. wholesale), the Quotient consulting practice, and an in-house model with a suite of internal tools released weekly to colleagues. Management also said it builds frontier-model costs into the price of client work.

"In fact, 93% of our wholesale trading in London is now digital and the time to process placements is reduced from 2 to 4 weeks to a couple of hours with Workbench."
— John Doyle, President & CEO

On the risk side, management voiced concern about heightened cyber exposure from AI and argued against broad AI exclusions in insurance policies, which it said would create confusion and gaps in cover.

Assessment: Workbench is the most concrete productivity metric Marsh has disclosed on AI: a placement cycle cut from weeks to hours is the kind of efficiency that should eventually show up in the margin. It has not yet, which is the gap between the AI narrative and the flat Q3. The policy-exclusion stance positions Marsh as the client's advocate, which is good for its franchise in an emerging risk class.

10. Digital Infrastructure: Stratus Follows Nimbus

Digital infrastructure remained a named growth driver across risk, capital advisory, credit and consulting. Marsh launched the Stratus Exchange, offering access to up to $10B of property coverage for operating data facilities, as a follow-on to Nimbus, its construction-phase facility. Management added that the investment around data-center construction is driving growth in Marsh Agency, and it argued that serving clients through the operational phase reduces the non-recurring element of construction work.

"Stratus is a natural follow-up to Nimbus our $2.7 billion insurance facility for construction risks."
— John Doyle, President & CEO

Assessment: Stratus is the important step because it converts a construction-cycle revenue stream into a recurring operating-risk one. Management again declined to size the revenue contribution, so this remains optionality rather than a modeled driver.

11. Capital Return: $2B Bought Back, $5.5B Plan Held

Uses of cash totaled $1.3B in Q3 and $4.0B through nine months: $1.4B of dividends, $607M of acquisitions and $2.0B of buybacks. The 2026 deployment plan of about $5.5B was reaffirmed, implying roughly $1.5B in Q4, and about $3.7B of repurchase authorization remains. Marsh repaid €550M of notes in September and plans to refinance them in euros in Q4.

"We continue to expect to deploy approximately $5.5 billion of capital in 2026 across dividends, acquisitions and share repurchases. The ultimate level of share repurchase will depend on how our M&A pipeline develops."
— Mark McGivney, COO & CFO

Assessment: Capital allocation remains disciplined and shareholder-friendly. The buyback pace slowed to $500M from $750M in Q2, which fits a higher share price and the Q3 cash timing; the Q4 split between buyback and acquisitions will depend on how the pipeline closes. Funding part of the year with commercial paper is reasonable at current rates but leaves less slack than a year ago.

Guidance & Outlook

The framework is unchanged on paper: growth similar to 2025, another year of margin expansion, solid EPS growth, about $5.5B deployed. What changed is the difficulty. Revenue is running ahead of the guide, so growth is safe. EPS is on track, with nine months up 9%. The margin is where all the remaining work sits, and the Q4 items management guided (higher corporate expense, lower fiduciary income, a flat Management Consulting quarter) make that work harder rather than easier.

Implied Q4: For the full-year adjusted margin to print above 27.1%, Q4 needs roughly 24.2-24.3% on about $7.05B of revenue, up about 50 basis points from 23.7%. For adjusted EPS, Q4 of $2.27-2.33 (up 7-10% from $2.12) would put the year at $10.56-10.62, or 8-9% growth, which fits "solid."

Street at: Full-year 2026 consensus sat near $10.40 before the print; the 6-cent beat alone lifts it toward $10.45-10.50. We are at about $10.60, assuming a Q4 near $2.31. For 2027, pre-print consensus sat around $11.25-11.38.

Guidance style: Conservative on revenue, where a 5% run rate sits under a 4%-style guide, and increasingly stretched on margin, where the guide was reiterated without a bridge. Management again declined to discuss 2027 until January.

Analyst Q&A Highlights

Whether AI and Thrive Change the Margin Outlook

The opening question asked how Marsh is using technology and AI to drive margin expansion, noting that peers have begun to describe their plans and linking the Thrive upsizing to it. Management stressed growth and client service before margin, named BCS, right-shoring, automation and early AI returns as levers, and declined to discuss 2027.

Q: "But maybe you could give us some more details on what you are doing with technology and AI to drive the margin expansion."
— Greg Peters, Raymond James

A: "I am not gonna speak to 27 on this call. Gregory, I will talk about that in January. But between BCS and not just AI, right shoring, automation, and the early returns from, you know, from AI. Are all levers for us to drive future efficiency."
— John Doyle, President & CEO

Assessment: The levers are named but unquantified, and the 2027 deferral is consistent with Marsh's January-guide habit. Combined with the Thrive upsizing, the answer supports a 2027 margin story but gives investors nothing to model until January.

Whether Marsh Needs to Answer Aon's USI Deal

An analyst raised the market's concern that Aon's large middle-market acquisition might push Marsh into a similar transaction. Management rejected the idea firmly, stressing the long history of its agency strategy, its discipline, and its preference for a steady sequence of smaller deals.

Q: "But you know, Aon's done this very large transaction. And, there is some concern in the marketplace that you might feel the need to respond with a similar big transaction."
— Greg Peters, Raymond James

A: "Our interest in the market is not recent... Not following anyone. We have the best middle market business in the industry... We have the capacity to do big deals, but you know, we are far more likely to do a string of pearls, continue that approach."
— John Doyle, President & CEO

Assessment: The clearest statement on the call, and a reassuring one. A reactive large deal would have been the biggest risk to the capital-allocation pillar; management closed that door explicitly.

How Much the Success-Fee Timing Contributed

An analyst asked management to size the revenue and earnings effect of the consulting success fees pulled into Q3. Management declined to give a figure but said the timing did not explain most of the growth and that success fees are becoming a larger part of how the business prices its work.

Q: "I was hoping you could give us a sense as to maybe the revenue and earnings impact of that?"
— Meyer Shields, KBW

A: "We wanted to point it out it is certainly not explaining the preponderance of growth. In management consulting even without that management consulting at a very strong growth quarter. But as Ted mentioned, success fees are becoming a big part. A bigger part of how we are structuring fees with clients."
— Mark McGivney, COO & CFO

Assessment: A partial answer. The full-year guide (high single digits, Q4 roughly flat) lets investors back into the timing effect, but the refusal to size it leaves the EPS beat's operating component harder to judge.

Why Reinsurance Lags Its Peers

An analyst noted that Reinsurance growth has been softer than peers' over recent quarters and asked about the split between new business and pricing, and whether 2027 looks similar. Management cited a portfolio overweight in property-cat and the U.S., noisy non-recurring items in the quarter, and client consolidation, and declined to make excuses.

Q: "I know it is a it is a smaller reinsurance quarter, but the growth there over the last 3 quarters has been or at least over the prior 2 has been softer than your peers."
— David Motemaden, Evercore ISI

A: "We are a bit overweight on property cat relative to some others. We are a bit overweight US, as well, compared to some others... We have been hit a little bit by some of the consolidation that is happened in the industry as well during the course of the year. But know, again, no excuses."
— John Doyle, President & CEO

Assessment: An honest answer that confirms the problem is structural to this cycle: the book is weighted toward exactly the lines where prices are falling fastest. Management did not commit to a 2027 trajectory, which we read as no near-term inflection.

Margin Expansion by Segment, and the Flat Quarter

An analyst asked whether the full-year margin expansion applies to both segments or only to the consolidated company. Management declined to guide by segment, reaffirmed company-level expansion, and acknowledged that the quarter's margin was flat.

Q: "I just wanted to clarify, do you guys expect margin improvement for the year in both segments or just on an overall basis?"
— Elyse Greenspan, Wells Fargo

A: "We do not guide by segment... Again, we wanna balance margin expansion with continued investment in future growth... And so delivered solid growth and adjusted EPS in the quarter, and margins were flat, but we do expect drive margin expansion for the year for the company."
— John Doyle, President & CEO

Assessment: The non-answer on segments is notable because Risk and Insurance Services is the segment whose nine-month margin is down. A company-level guide leaves room for consolidated expansion through Consulting and corporate even if the larger segment slips.

Hiring Versus Margin: Which Comes First

An analyst asked how far Thrive and AI savings are funding more hiring, and how management balances that against margin improvement. The answer was the clearest statement yet of management's priorities: growth first, margin as a by-product, with mid- and back-office attrition now being harvested.

Q: "to what degree is that allowing you to begin investing more in hiring? And how do you balance that versus the margin improvement as we think in the next year?"
— Alex Scott, Barclays

A: "We wanna continue to drive growth in the business and while, really, margin expansions and outcome of the way we run the business, it is not really primary KPI. For us inside of the company... we have begun to harvest some attrition really in our mid and back office."
— John Doyle, President & CEO

Assessment: The most consequential tone shift on the call. Management is preparing investors to accept smaller margin gains in exchange for growth investment, which is defensible strategy but a change from a story the market has priced for 18 years. Harvesting back-office attrition is the mechanism that could reconcile the two.

Whether Transactional and Data-Center Demand Slowed After Quarter-End

An analyst asked whether transactional risk, construction or digital-infrastructure activity had slowed in September and October. Management said no, describing strong demand through the quarter and strong pipelines in both segments.

Q: "I think things have maybe slowed down in September and then October. So is that something on any of those fronts that we should be considering then to the end of the year?"
— Alex Scott, Barclays

A: "Nope. I mean, for our business, you know, demand remained pretty strong through the quarter. Our pipelines remain in both of those both segments of our business remain strong as well."
— John Doyle, President & CEO

Assessment: A direct denial of a late-quarter slowdown, which supports the Risk growth run rate into Q4. The answer was qualitative, so we take it as positive but unverified until the fourth-quarter print.

Where Marsh Stands on AI Policy Exclusions

An analyst asked about media coverage of brokers opposing broad AI exclusions in insurance policies. Management said broad exclusions would create confusion because AI is embedded in most workflows, and set out a framework separating AI as an evolution of existing perils from AI as a source of new gaps.

Q: "You know, I know there is been some media coverage about brokers being against broad AI exclusions and policies."
— Rob Cox, Goldman Sachs

A: "The first category is just where AI is an elaboration or an evolution of an existing risk or peril. And, you know, it will be impossible to unbundle it from the causal pathways to whatever outcome may be. And that is really where we were focused on not excluding things which we think would lead to uncertainty to contention, to gaps in cover."
— Nick Studer, CEO, Risk

Assessment: A thoughtful position that serves clients and, over time, the broker: if AI risk is absorbed into existing coverage rather than excluded, demand for advice on aggregation and terms grows. It is a modest but real franchise positive in an emerging risk.

What They're NOT Saying

1. No Q4 margin bridge. The full-year margin now depends on one quarter, and management again described the path only directionally. There was no Q4 phasing language this time at all, after July's "more margin expansion in the fourth quarter than in the third quarter."
2. No 2027 framework. Management explicitly deferred 2027 to January, including whether the upsized Thrive savings will lift margins or be reinvested in sales capacity.
3. AltamarCAM went unmentioned. The private-markets acquisition announced at Q1 and expected to close later in 2026 appears nowhere in the release, the call or the 10-Q, and it is not among the year's closed acquisitions. A quiet slip in a regulatory approval would not be material, but the silence leaves the timing unknown.
4. The success-fee pull-forward was not sized. Asked directly, management said only that it did not explain most of Management Consulting's growth.
5. Digital-infrastructure and transactional revenue stayed undisclosed. Asked for the contribution to U.S./Canada growth, management declined to give one, so the most-cited new growth leg is still unquantified.
6. The cash-flow decline was not discussed. Nine-month operating cash flow fell 26%; the call noted only that Greensill payments sit in the cash-flow statement. The 10-Q offers only its standard description of working-capital timing, and neither source sized the Greensill cash; the cash-flow statement shows receivables absorbing $872M against $388M a year ago.
7. No producer-headcount data. Management credited hiring for growth and said it is now harvesting back-office attrition, but gave no net headcount or producer figures.

Market Reaction

• Pre-print setup: Marsh closed at $178.40 on October 14, down 3.8% year to date against an S&P 500 up 12.8%, down 12.5% over twelve months and down 0.8% over the trailing 30 days, within a 52-week closing range of $157.32-$207.02. Since our July note the stock had slipped 1.8% while the S&P rose 2.8%. Aon fell 23.4% over the same stretch after its USI announcement.
• Reaction session (October 15, before-the-open release, 8:30 AM ET call): Shares opened at $182.80 (+2.5%), traded between $181.20 and $191.04, and closed at $186.54, up 4.6% (+$8.14), on 4.2M shares, 1.5x the 30-day average. The S&P 500 rose 0.3%.
• Peers that day: Aon rose 4.2%, Gallagher 5.5%, WTW 4.5% and Brown & Brown 4.9%, so Marsh moved with the group rather than ahead of it.
• Following sessions: Marsh closed at $191.26 on October 20 and $199.27 on October 22, when the whole broker group rose 4-6% against a 1.2% decline in the S&P 500. From the pre-print close, Marsh is up 11.7%, against 11.4% for Aon, 14.3% for Gallagher, 11.8% for WTW and 15.0% for Brown & Brown, while the S&P fell 0.7%.
• Street response: The one post-print price-target change we found was an increase. The average Street target sits near $206, only about 3% above the current price, and the consensus rating is closer to neutral than positive.

A group move, not a Marsh-specific re-rating. Marsh typically reports first among the large brokers, and the market appears to have read its print as a read-through for the sector: organic growth steady at 5%, the flagship broker accelerating, and property pricing falling less steeply. Every major peer rose by a similar amount the same day. The flat margin cost Marsh nothing on the day, which tells us investors weighted the growth signal and the Thrive upsizing over the margin miss against our test.

The rally since has outrun the evidence. The group has kept rising through the week, including a sharp move on October 22 that came on a down day for the broader market and for which we found no company-specific catalyst. Brokers sold off earlier in the year on fears that AI would disintermediate them, so part of this looks like a continued unwinding of that discount, possibly helped by a defensive rotation on a down day for the market. For Marsh specifically, the stock now trades at 18.8x our 2026 estimate, against 17.5x on the same basis in July. The multiple has expanded in a quarter when the margin did not, which raises the bar for Q4.

Street Perspective

Debate: Is the Flat Margin a Problem or a Choice?

Bull view: Management is choosing to reinvest Thrive savings into producers and capabilities while growth is available, and the 5% organic rate shows the investment is working. The upsized $600M program provides the savings to expand margins in 2027, and an 18-year record earns the benefit of the doubt for Q4.

Bear view: Two quarters of waiting for the back half have produced a flat Q3 and a nine-month decline, management has stopped describing Q4 phasing, and the CEO is now calling margin a by-product. The market pays a premium multiple partly for the margin streak; if it ends, the multiple should follow.

Our take: The bull reading of the strategy is right, but the bear reading of the evidence is fair. We still expect a small full-year expansion, and we would not chase the stock until Q4 shows it.

Debate: Can 5% Organic Growth Hold Into 2027?

Bull view: Risk accelerated against a falling rate index, Health recovered, digital infrastructure and transactional risk are expanding the addressable market, and the guide was not raised despite a 5% run rate, leaving room for upside.

Bear view: Reinsurance stays negative through January 1, Management Consulting borrowed from Q4, casualty pricing is cooling, and fiduciary income keeps falling with rates. The ingredients for a 4% year are more visible than those for a 6% year.

Our take: We model 4-5% for 2027 with the core broker near 5%. The question is no longer whether growth holds but whether it can carry margin expansion on its own.

Debate: After an 11.7% Week, Accumulate or Wait?

Bull view: Even after the rally, Marsh trades at about 17.5x 2027 earnings for steady 5% organic growth, falling share count, a 2% dividend and a resolved Greensill tail; Marsh itself traded near 22x as recently as mid-2025.

Bear view: The stock has re-rated by more than a full turn in a quarter of flat margins, the group move has no clear catalyst, and the average Street target is barely above the current price.

Our take: Hold the position and stop adding. Our fair value still sits above the price, but the margin of safety that made Marsh attractive at 17.5x 2026 earnings in July has narrowed. We would add again on a pullback toward the high $180s or on a clean Q4 margin.

Model Update & Valuation Framework

Valuation framework: At the October 22 close of $199.27, Marsh trades at about 18.8x our 2026 adjusted EPS estimate of ~$10.60 and 17.5x our 2027 estimate of ~$11.40. On the same 2026 basis, the stock traded at 17.5x after our July note ($181.59 on ~$10.40), so it has re-rated by more than a full turn. We keep the 20-22x multiple on 2026E for continuity, which with the higher estimate gives fair value of roughly $212-233 (about 18.6-20.5x 2027E). That is about 6-17% above the current price, roughly 12% to the midpoint, plus a ~2.0% dividend yield. The range moved up only modestly (from $208-229) because the earnings estimate rose; the price closed most of the gap.

Thesis Scorecard Post-Earnings

Grading the standing thesis (Outperform since the Q4 2025 upgrade, maintained at Q1 and Q2 2026).

Q2 Commitments Revisited

Overall: Thesis intact on growth and capital, weaker on margin. The revenue base is doing everything the thesis asked, the capital-allocation pillar strengthened with the explicit rejection of a large deal, and Greensill is closed. Against that, the one commitment we called decisive in July was missed, management's language on margin softened, and the stock re-rated anyway. Conviction moves down a notch, from 7 to 6.

Action: Maintain Outperform at a fair value of roughly $212-233. Hold existing positions but stop adding at ~$199; we would add again on a pullback toward the high $180s or on evidence of Q4 margin expansion. If the stock moves into our fair-value range without that evidence, or if Q4 ends the expansion streak, we would revisit the rating. Watch: the Q4 adjusted margin (the deciding number), the January 2027 framework and how much of the Thrive savings is reinvested, Reinsurance at the January 1 renewals, and the AltamarCAM close.